Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.

Recently, licensed and emerging treatments for metastatic castrate-resistant prostate cancer are transforming ... to confer a terminal prognosis, with a median survival of 12 months from ...

We use cookies in order to ensure that you can get the best browsing experience possible on the Council website. Certain cookies are used to obtain aggregated statistics about website visits to help ...

It’s about time your voice is heard in medical research. Your journey through prostate health and clinical trials is unique. Understanding PSA, breaking stigmas, ensuring diversity in clinical trials, ...

Line source synthesis is the science of choosing this distribution function to give a radiation pattern with prescribed properties such as, for example, narrow angular width of the main lobe and low ...

In a study involving a large family with CMT1B, enlargement of the median and vagus nerves was detected in affected family members.34 Conversely, sural nerve calibre was reduced, possibly reflecting ...

Catch up on all the notable drug and device approvals in urology over the past year.